What to expect when taking Lexapro or Risperdal- risperidone 

Master Formulas Natural Medical Alternatives

Water & What Should Be In it!

Healthy Weight LossLinking Friends




What I found that you can expect when taking Lexapro or
Risperdal- risperidone 

Your concern over the damage being done by the drugs is something you should take a look at and I suspect you already knew they weren't good for you or you wouldn't have made that comment!
 

People usually do not look at the negatives of the medications they take but I am going to show them… People think their doctor would not give them something to harm them. I’m not one of those as I've been there and watched it consistently happen for more than twenty years! 

First look at Lexapro;  

Liquid and tablets Contains: Escitalopram oxalate occurs as a fine, white to slightly-yellow powder and is freely soluble in methanol and dimethyl sulfoxide (DMSO), soluble in isotonic saline solution, sparingly soluble in water and ethanol, slightly soluble in ethyl acetate, and insoluble in heptane. 

The tablets also contain the following inactive ingredients: talc, croscarmellose sodium, microcrystalline cellulose/colloidal silicon dioxide, and magnesium stearate. The film coating contains hypromellose, titanium dioxide, and polyethylene glycol. 

Lexapro oral solution contains escitalopram oxalate equivalent to 1 mg/mL escitalopram base. It also contains the following inactive ingredients: sorbitol, purified water, citric acid, sodium citrate, malic acid, glycerin, propylene glycol, methylparaben, propylparaben, and natural peppermint flavor. 

Lena's remark; I see nothing in there that will nourish or support the brain but lots that can interrupt the electrical impulses need to control the organs of the body!  These drugs can impair the oxygen flow through the brain that can and most likely does create worse Halitosis!

Then Risperdal 

Risperdal- risperidone 

RISPERDAL ® is used for the treatment of schizophrenia in adults and adolescents ages 13-17 years.  

RISPERDAL ® is used alone or in combination with other medicines (valproate or lithium) in adults for the short-term treatment of bipolar mania; or alone in adults, children and adolescents ages 10-17 years for the short-term treatment of bipolar mania.  

RISPERDAL ® is used for the treatment of irritability associated with autistic disorder in children and adolescents ages 5-16 years. 

Risperidone is a white to slightly beige powder. It is practically insoluble in water, freely soluble in methylene chloride, and soluble in methanol and 0.1 N HCl. 

RISPERDAL® tablets contain the following inactive ingredients: colloidal silicon dioxide, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, propylene glycol, sodium lauryl sulfate, and starch (corn). The 0.25 mg, 0.5 mg, 2 mg, 3 mg, and 4 mg tablets also contain talc and titanium dioxide. The 0.25 mg tablets contain yellow iron oxide; the 0.5 mg tablets contain red iron oxide; the 2 mg tablets contain FD&C Yellow No. 6 Aluminum Lake; the 3 mg and 4 mg tablets contain D&C Yellow No. 10; the 4 mg tablets contain FD&C Blue No. 2 Aluminum Lake. 

WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS [They actually have this warning on their website so it must be a huge problem or they wouldn'y put it quite that way!] 

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of 17 placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients. Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase mortality. The extent to which the findings of increased mortality in observational studies may be attributed to the antipsychotic drug as opposed to some characteristic(s) of the patients is not clear. RISPERDAL® (risperidone) is not approved for the treatment of patients with dementia-related psychosis. 

The most common adverse reactions observed in all clinical trials with RISPERDAL ® occurring at a rate of at least 10% were somnolence [a state of near-sleep, a strong desire for sleep, or sleeping for unusually long periods (hypersomnia). It has two distinct meanings, referring both to the usual state preceding falling asleep, and the chronic condition referring to being in that state independent of a circadian rhythm. The disorder characterized by the latter condition is most commonly associated with the use of prescription medications] Also may experience increased appetite, fatigue, rhinitis, upper respiratory tract infection, vomiting, coughing, urinary incontinence, increased saliva, constipation, fever, tremors, muscle stiffness, abdominal pain, anxiety, nausea, dizziness, dry mouth, rash, restlessness, and indigestion.  Faintness or lightheaded when they stand up or sit up too quickly.  

Neuroleptic Malignant Syndrome (NMS) potentially fatal side effect reported with RISPERDAL ® and similar medicines. Call your doctor immediately if the person being treated develops symptoms such as high fever; stiff muscles; shaking; confusion; sweating; changes in pulse, heart rate, or blood pressure; or muscle pain and weakness. Treatment should be stopped if the person being treated has NMS.  

Tardive Dyskinesia (TD) is a serious, sometimes permanent side effect reported with RISPERDAL ® and similar medications. TD includes uncontrollable movements of the face, tongue, and other parts of the body. The risk of developing TD and the chance that it will become permanent is thought to increase with the length of therapy and the overall dose taken by the patient. This condition can develop after a brief period of therapy at low doses, although this is much less common. There is no known treatment for TD, but it may go away partially or completely if therapy is stopped.  

RISPERDAL ® and similar medications can raise the blood levels of a hormone known as prolactin, causing a condition known as hyperprolactinemia. Blood levels of prolactin remain elevated with continued use

Some side effects seen with these medications include the absence of a menstrual period; breasts producing milk; the development of breasts by males; and the inability to achieve an erection. The connection between prolactin levels and side effects is unknown.  

High blood sugar and diabetes have been reported with RISPERDAL ® and similar medications. If the person being treated has diabetes or risk factors such as being overweight or a family history of diabetes, blood sugar testing should be performed at the beginning and throughout treatment. Complications of diabetes can be serious and even life threatening. If signs of high blood sugar or diabetes develop, such as being thirsty all the time, going to the bathroom a lot, or feeling weak or hungry, contact your doctor.  

RISPERDAL ® should be used cautiously in people with a seizure disorder, who have had seizures in the past, or who have conditions that increase their risk for seizures.  

Some people taking RISPERDAL  By standing up or sitting up slowly and following your healthcare professional's dosing instructions, this side effect may be reduced or it may go away over time.  

Extrapyramidal Symptoms (EPS) are usually persistent movement disorders or muscle disturbances, such as restlessness, tremors, and muscle stiffness. If you observe any of these symptoms, talk to your healthcare professional.  

Taken from their own website:  

IMPORTANT SAFETY INFORMATION FOR RISPERDAL ®  

Elderly Patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an increased risk of death compared to placebo. RISPERDAL ® (risperidone) is not approved for the treatment of patients with dementia-related psychosis.

Senior's bodies are made exactly as those younger so this is not limited to just elderly! I wouldn't put those chemicals in my body if I thought I was dying as it would definitely speed my death!